Home
University & Research Institutions

Sector: University & Research Institutions

Patent transactions in Q2 2023 soared by 345% YOY

The surge is due to 9,702 US patent assets involved in the BlackBerry sale to Key Patent Innovations, which runs Malikie Innovations, according to the AST Patent Deals Report for Q2 2023

$227 million Apollo Therapeutics investment is a major boost for innovative tech transfer approach

Pathbreaking joint venture between academia and Big Pharma addresses university IP monetisation challenges

RegenxBio/Sarepta dispute highlights strategic challenges for gene therapy developers

Narrow safe harbor immunity and platform technology patents are creating both pitfalls and opportunities

Latest content

From academy to industry: China’s new trend and policies on academic technology transfer

Featured in IAM Life Sciences: Key issues for senior life sciences executives 2022

Most universities and research institutes in China are government-funded, and university-generated intellectual property is considered state-owned property, making concern over the improper disposal, or even loss of, state-owned property the most prominent issue of academic technology transfers.

18 August 2022

Mysterious patent-purchasing biotech now embroiled in trade secrets dispute

New market entrant Terran Biosciences takes action against rival Compass Pathways in Maryland district court

17 August 2022

UK government blocks IP deal with Chinese company using radical new powers

Recently implemented legislation gives the British government the ability to intervene in IP transactions

22 July 2022

There are dangers in excluding the unvaccinated from jury service in US patent cases

Courts striking-out those who have not had covid-19 jabs may unintentionally be eliminating people from diverse demographics holding multiple world views

16 July 2022

Royalty Pharma spends $1.3 billion in latest drug revenue rights purchase

Royalty transactions are an increasingly attractive means of cashing in on life sciences innovation, and the returns can be significant

15 July 2022

Data monetisation gathers momentum in the healthcare sector

Life sciences innovators are increasingly paying for access to high-quality data

27 June 2022

French appeal court SPC decision is good news for biologics innovators

Following a string of adverse rulings against inventors, Paris Court of Appeal overturns patent office rejection of supplementary protection certificate on Article 3(a) grounds

20 June 2022